Glycemic control is the primary mediator of diabetic microvascular complications and also contributes to macrovascular complications. A new study (see related article beginning on page 1049) reveals a previously unrecognized association between oxidant activation of poly(ADP ribose) polymerase (PARP) and upregulation of known mediators of glycemic injury. Inhibitors of PARP may have potential therapeutic roles in the prevention of diabetic complications.
Jane E.B. Reusch
Title and authors | Publication | Year |
---|---|---|
Role and mechanism of miRNA in cardiac microvascular endothelial cells in cardiovascular diseases.
Yan J, Zhong X, Zhao Y, Wang X |
Frontiers in Cardiovascular Medicine | 2024 |
Identifying diagnostic indicators for type 2 diabetes mellitus from physical examination using interpretable machine learning approach
Lv X, Luo J, Huang W, Guo H, Bai X, Yan P, Jiang Z, Zhang Y, Jing R, Chen Q, Li M |
Frontiers in Endocrinology | 2024 |
The protective effects of alpha-pinene on high glucose-induced oxidative stress and inflammation in HepG2 cells
Choghakhori R, Azadpour M, Abbasnezhad A, Ebrahimzadeh F, Ahmadvand H |
Iranian Journal of Basic Medical Sciences | 2024 |
Do modifiable patient factors increase the risk of postoperative complications after total joint arthroplasty?
Baran JV, Rohatgi A, Redden A, Fomunung C, Goguen J, John DQ, Movassaghi A, Jackson GR, Sabesan VJ |
Archives of orthopaedic and trauma surgery | 2024 |